• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Transmedics wraps up $35.4 million VC round

Transmedics wraps up $35.4 million VC round

March 3, 2010 By MassDevice staff

“Beating-heart” transport specialist Transmedics Inc. closed on new funding totaling $35.4 million, including the conversion of about $9 million of debt.

The Andover, Mass.-based company markets the Organ Care System, a portable container designed to carry hearts, kidneys and other organs between surgical facilities prior to transplant. Roughly the size of a kitchen trash compactor, the battery-powered unit continuously bathes organs in warm, oxygenated blood, replicating conditions inside the body and reducing tissue damage and decay compared with traditional methods of keeping organs on ice during transport.

The new funding round, Transmedics‘ fifth since its 1998 founding, was disclosed in documents filed March 1 with the Securities & Exchange Commission. The filing did not specify individual investors; previous funding rounds were led by Tudor Investments, Flagship Ventures, CB Health Ventures and the U.S.-based arm of 3i Venture Capital, which owned nearly one-quarter of Transmedics stock prior to the current round.

Overall, venture capital firms owned well over 85 percent of all Transmedics common and preferred shares, according to preliminary offering documents filed as part of company efforts for a proposed initial public offering of stock launched in September 2007. The company pulled the IPO bid, citing unfavorable market conditions, in December 2008 and after raising $11.2 million from its existing investor pool a few months earlier.

The OCS currently is cleared for use in heart transplants in Europe and Australia. The company in April 2007 began the pilot trial phase for an investigational device exemption at five centers in the U.S., including Brigham & Women’s Hospital in Boston. The company last year also proposed trials for “a device that is not approved or cleared by the U.S. FDA,” but appears to have not yet acted on that request.

Transmedics CEO Wallen Hassanein was traveling this week and did not return telephone calls seeking comment.

Filed Under: Business/Financial News, News Well Tagged With: transmedics

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy